The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
Help: Registration number
ACTRN12626000710325
Ethics application status
Help: Ethics application status
Approved
Date submitted
Help: Date submitted
17/05/2026
Date registered
Help: Date registered
15/06/2026
Date last updated
Help: Date last updated
15/06/2026
Date data sharing statement initially provided
Help: Data sharing statement date
15/06/2026
Type of registration
Help: Type of registration
Prospectively registered

Titles & IDs
Public title
Somfit - Paediatric forehead wireless monitoring device for sleep analysis
Scientific title
Evaluating the sleep staging capability of the Somfit Paediatric forehead wireless monitoring device in children
Additional trial identifiers [1] 317315 0
CT-2025-CTN-05565-1 v2
Universal Trial Number (UTN)
Trial acronym
Related trial records

Health condition
Health condition(s) studied:
Sleep apnoea 342238 0
Condition category
Condition code
Respiratory 338033 338033 0 0
Sleep apnoea

Intervention/exposure
Study type
Interventional
Description of the intervention or exposure
Application of Somfit wireless forehead sleep monitoring device by trained paediatric sleep scientists during in-hospital polysomnography being conducted over a single night (minimun 6 hours, maximum 14 hours) as part of usual care. Somfit is a wearable device for collecting patients’ physiological data, that includes a single-use adhesive-gel electrode placed on the forehead, and the Somfit device, which is pressed onto the electrode.
Intervention code [1] 334093 0
Diagnosis / Prognosis
Description of the comparator or control
Comparator is participant’s own polysomnography conducted at the same time as somfit monitoring
Control group
Active

Outcomes
Primary outcome [1] 345440 0
Agreement between automated sleep staging performed using the Somfit sleep wireless monitoring device with sleep staging performed by humans using diagnostic PSG (Level 1 Attended Sleep Study) is the primary outcome.
Timepoint [1] 345440 0
Single time point after completion of simultaneous polysomnography and Somfit sleep monitoring/recording
Secondary outcome [1] 461681 0
For the outcome of apnoea hypopnea index (AHI), we will compare the Somfit-predicted AHI with the polysomnography-determined AHI by presenting a Bland-Altman difference plot, and quantify the average difference between these two metrics.
Timepoint [1] 461681 0
Single time point after completion of simultaneous polysomnography and somfit sleep monitoring/recording
Secondary outcome [2] 462817 0
Parent/Patient satisfaction
Timepoint [2] 462817 0
Upon completion of the wearing of the Somfit

Eligibility
Key inclusion criteria
Undergoing in-hospital polysomnography as part of routine care
Minimum age
4 Years
Maximum age
18 Years
Sex
Both males and females
Healthy volunteers
No
Key exclusion criteria
• Treatment (including continuous positive airway pressure, mechanical ventilation, or supplemental oxygen) is commenced during The polysomnography study

Study design
Purpose of the study
Diagnosis
Allocation to intervention
Non-randomised trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Masking / blinding
Open (masking not used)
Who is / are masked / blinded?



Intervention assignment
Single group
Other design features
Phase
Not Applicable
Type of endpoint/s
Statistical methods / analysis

Recruitment
Recruitment status
Not yet recruiting
Date of first participant enrolment
Anticipated
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
QLD

Funding & Sponsors
Funding source category [1] 321882 0
Hospital
Name [1] 321882 0
Queensland Children’s Hospital
Country [1] 321882 0
Australia
Primary sponsor type
Hospital
Name
Queensland Children’s Hospital
Address
Country
Australia
Secondary sponsor category [1] 324742 0
None
Name [1] 324742 0
Address [1] 324742 0
Country [1] 324742 0

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 320421 0
Children’s Health Queensland Hospital and Health Service Human Research Ethics Committee
Ethics committee address [1] 320421 0
Ethics committee country [1] 320421 0
Australia
Date submitted for ethics approval [1] 320421 0
Approval date [1] 320421 0
19/01/2026
Ethics approval number [1] 320421 0

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 150430 0
Dr Ajay Kevat
Address 150430 0
Queensland Children’s Hospital, 501 Stanley Street, South Brisbane, Queensland, Australia 4101
Country 150430 0
Australia
Phone 150430 0
+61400252987
Fax 150430 0
Email 150430 0
Contact person for public queries
Name 150431 0
Ajay Kevat
Address 150431 0
Queensland Children’s Hospital, 501 Stanley Street, South Brisbane, Queensland, Australia 4101
Country 150431 0
Australia
Phone 150431 0
+61730682300
Fax 150431 0
Email 150431 0
Contact person for scientific queries
Name 150432 0
Ajay Kevat
Address 150432 0
Queensland Children’s Hospital, 501 Stanley Street, South Brisbane, Queensland, Australia 4101
Country 150432 0
Australia
Phone 150432 0
+61730682300
Fax 150432 0
Email 150432 0

Data sharing statement
Will the study consider sharing individual participant data?
No


What supporting documents are/will be available?

No Supporting Document Provided


Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.